Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 155.11M P/E 47.85 EPS this Y -93.10% Ern Qtrly Grth -34.20%
Income 3.97M Forward P/E 27.04 EPS next Y 475.00% 50D Avg Chg 22.00%
Sales 46.49M PEG 11.78 EPS past 5Y - 200D Avg Chg 40.00%
Dividend N/A Price/Book N/A EPS next 5Y 13.20% 52W High Chg -
Recommedations 3.00 Quick Ratio 3.31 Shares Outstanding 24.94M 52W Low Chg 103.00%
Insider Own 1.90% ROA -1.52% Shares Float 11.49M Beta 2.41
Inst Own 70.85% ROE - Shares Shorted/Prior 95.67K/543.49K Price 6.22
Gross Margin 80.92% Profit Margin 8.54% Avg. Volume 304,101 Target Price 6.23
Oper. Margin -5.22% Earnings Date Nov 2 Volume 267,682 Change 0.00%
About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company has license agreement with Everest Medicines Limited to develop and commercialize XERAVA; and PAION AG to commercialize GIAPREZA and XERAVA. La Jolla Pharmaceutical Company was incorporated in 1989 and is based in Waltham, Massachusetts. As of August 22, 2022, La Jolla Pharmaceutical Company operates as a subsidiary of Innoviva, Inc.

LJPC Chatroom

User Image BeefStewart Posted - 11/15/23

@the_shalashaska I agree! Vaguely reminds me of $LJPC before it was acquired... While I don't know if we will get the premium we are hoping for, the company is an excellent acquisition target, in my opinion.. Durable revenue streams with the opportunity to scale up. I imagine at least one group of investors would be interested...

User Image cielo1 Posted - 10/16/23

$DMTTF $CELG $JUNO $LJPC Small Pharma buy-out complete in a string of massive value acquisitions. Next on tap $IFRX, hopefully near $50 per share! Kindest regards to all!

User Image BeefStewart Posted - 07/12/23

$ADMA When $LJPC was acquired for 6.23 a share, the article linked below mentioned the 30 day volume-weighted average share price when discussing the premium. I wonder if the current aggressive shorting of Adma is intended to lower the average share price to make an acquisition less expensive for a potential suitor. https://www.businesswire.com/news/home/20220711005433/en/Innoviva-to-Acquire-La-Jolla-Pharmaceutical-Company

User Image BeefStewart Posted - 11 months ago

$ADMA I feel like many stocks trade in a boring range before being acquired. $CMPI $CCXI $LJPC Weren't these similarly trading in a boring sideways pattern before being acquired? Maybe not. My memory might not be accurate. I thought there was some similarity in trading action, though.

User Image stockilluminati Posted - 05/11/23

$LJPC https://www.stockilluminati.com/ljpc/display.php?url=https://clinicaltrials.gov/ct2/show/NCT05851326 - trial update posted here!

User Image WarnedUBoutStoney Posted - 05/11/23

$ZURA Man this scam is still around huh. I remember this being pumped along with $AEZS $LJPC and $GBSN .

User Image WarnedUBoutStoney Posted - 1 year ago

@eloquentpanda Better one is $LJPC - ST chart won't show it but it was once 117500 or so.

User Image cielo1 Posted - 04/17/23

$IFRX wow Tang good old $LJPC days!! Kindest regards to all!

User Image BeefStewart Posted - 04/14/23

@VoxGeorge this is reminding me of $LJPC

User Image BeefStewart Posted - 1 year ago

$ADMA $CCXI $CMPI $LJPC Each of those tickers reminds me of adma for some reason. Feel free to take a look at how each of them traded prior to acquisition... Who knows? Certainly not me.

User Image BeefStewart Posted - 03/28/23

@VoxGeorge Right now, it's smelling like my cousin after she falls asleep for a week with a half-eaten party-sized pizza in her lap. But that said, I am of the mind that there are ongoing negotiations for some sort of merger or acquisition. My most basic reasoning is that they continue to engage Morgan Stanley, and continue to be majority owned by institutions who I believe would be motivated to quickly turn a profit on their investment. Additionally, looking back at past buyouts such as $LJPC, I believe their shares were trading kinda flat/sideways for at least a little while before being snapped up at a significant premium. This type of sideways action is unreasonable to me, and I suspect it is leading to something positive for us. That said, I have no idea 🤪

User Image risenhoover Posted - 03/26/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/25/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/24/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/23/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/22/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image BeefStewart Posted - 03/21/23

$ADMA to me, this is trading like it's going to be bought out. I am probably wrong, but the sharp price decline to below $3 suggests that a $6 buyout at a "100%" premium may be imminent... I'm kind of reminded of $LJPC when it was trading sideways, if memory serves correctly, before being bought out for over $6 at around a 100% premium.

User Image risenhoover Posted - 03/20/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/19/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/18/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/17/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/16/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/15/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image risenhoover Posted - 03/14/23

$LJPC LJPC / La Jolla Pharmaceutical Company Price Target Updated https://fintel.io/sfo/us/ljpc?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image Notthenorm1023 Posted - 1 year ago

@Imregarded @DonJohnson24 $APRN Response: To Imegarded Okay tard...... Any company HQ'd in La Jolla, is overvalued and a scam. La Jolla translated in Spanish is the Jewel. Are you w/ me still. $PROG was a scam stock picked up for pennies by $BIOR, still with me? I live in La Jolla, there's a beach called Blacks Beach. Still with me? There are BBQ's (At Blacks) and you party with naked chicks, drink beer, sun. I could tell you about $LJPC but another time? Comprende????????????? I think you wear the stupidity sombrero https://en.wikipedia.org/wiki/Black%27s_Beach

User Image Americas_War_Machine Posted - 1 year ago

$BCRX just gotta wait now. Just like $LJPC just a matter of time. Got a low enough average and can park the money here.

User Image cctranscripts Posted - 02/14/23

Roderick Wong just issued a filing suggesting it has sold all of its La Jolla Pharmaceutical https://www.conferencecalltranscripts.org/summary/?id=11807163 $LJPC

User Image cheating_stock_investor Posted - 02/07/23

@timpfnb1 never ignore your gut feeling! Lol I did with $ljpc years ago and there was good reason I should had listened to it.

User Image Dh2tm Posted - 12/20/22

$LJPC lawsuit scanner: https://lawow.org/finger-v-la-jolla-pharmaceutical-company-et-al-2022-08-04

User Image biotickr Posted - 12/11/22

Drug pipe for $LJPC is shaping up. Screenshot from https://biotickr.com/biotech-stocks/united-states-of-america/ljpc-la-jolla-pharmaceutical-co

Analyst Ratings
H.C. Wainwright Neutral Nov 26, 19
SunTrust Robinson Humphrey Hold Nov 25, 19
JP Morgan Neutral Jan 23, 19
Jefferies Hold Jan 14, 19
JP Morgan Underweight Aug 10, 18
Jefferies Underperform Aug 9, 18
H.C. Wainwright Buy Dec 21, 17
JP Morgan Underweight Dec 8, 17
JP Morgan Overweight Aug 30, 17
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Johnson Craig A Director Director Jul 08 Option 3.93 12,000 47,160 12,000 07/12/22
RAMSAY DAVID A Director Director Dec 02 Buy 3.75 24,500 91,875 100,000 12/06/21
- - - Jun 01 Buy 4.45 245,020 1,090,339 10,049,224 06/01/21
RAMSAY DAVID A Director Director May 26 Buy 3.51 20,000 70,200 68,000 05/26/21